Norel & Nature opens Asia-Pacific representative office

Keyword:
Publish time:6/19/2008 12:00:00 AM      Source: www.cnchemicals.com
Information collection and data processing:  CCM     For more information, please contact us
June 19, 2008
Norel & Nature opens Asia-Pacific representative office
Press Release

Spanish animal nutrition company Norel & Nature has recently opened its first representative office in Asia, based in Singapore, a city-state which is the hub of the Asia-Pacific region and well connected to the rest of the world.

The opening of the office signifies a new milestone for the company, with the purpose of strengthening its current business in the region and developing new activities.

Business Development Director Diana Pablos Velez said the decision is part of Norel & Nature''s willingness to strengthen its network on an international basis.

The new office will be primarily focused on offering technical support and is part of the company''s worldwide effort to build up long-term relationship with their customers, according to Velez.

Mathieu Cortyl has been appointed as the general manager of the Asia-Pacific office and Velez said his excellent knowledge of the feed industry would help the company to maximise business opportunities.

Velez said his appointment would also allow distributors and their customers to be in closer contact with the company and that the company would be better informed of market developments.

Cortyl said, "The Asia and Pacific markets offer tremendous growth potential in our segment, and I am thrilled that Norel & Nature gives me the opportunity to provide their efficient and cost effective solutions to local and global customers".

Based in Spain, Norel & Nature operates in over 50 countries worldwide from 6 factories on 3 continents (Spain, Egypt and Mexico), with its expertise in advanced animal nutrition technology as its strength. The company is also a market leader in the production of rumen-protected fats and a manufacturer of animal feed additives due to its constant research and agreements with biotechnological institutions.